Assessment of off-label prescribing: profile, evidence and evolution
Objectives: The objectives of the study were to describe the extent and profile of off-label prescriptions, to evaluate the level of evidence supporting these indications, to assess the research activity in these conditions, and to determine to what extent these were authorized as new indications fi...
Saved in:
Main Authors: | Encarnación Blanco-Reina (Author), Azucena Muñoz-García (Author), Medical Research Centre (CIMES) (Author), Ricardo Ocaña-Riola (Author), José Ramón del Prado-Llergo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ETHICS OF PRESCRIBING OFF-LABEL DRUGS IN CHILDREN. THE DILEMMA OF SILDENAFIL
by: Laszlo-Zoltan Sztankovszky, et al.
Published: (2015) -
Off-Label Prescribing in Pediatric Population-Literature Review for 2012-2022
by: Valentina Petkova, et al.
Published: (2023) -
Antidepressant use and off-label prescribing in primary care in Spain (2013-2018)
by: Cristina Espín Martínez, et al.
Published: (2022) -
Exploratory Findings of Prescribing Unlicensed and Off-Label Medicines Among Children and Neonates
by: Shakeel S, et al.
Published: (2020) -
Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring
by: Fegert Joerg M, et al.
Published: (2008)